Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Leone

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nature Communications|November 17, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosisSadiya Parveen, Jessica Shen, Shichun Lun, et al.
Science Immunology|March 14, 2025
QRICH1 mediates an intracellular checkpoint for CD8<sup>+</sup> T cell activation via the CARD11 signalosomeNicole M Carter, Wihib D Hankore, Yong-Kang Yang, et al.
Cancer Research Communications|September 2, 2022
Interrogation of T Cell-Enriched Tumors Reveals Prognostic and Immunotherapeutic Implications of Polyamine MetabolismR Alex Harbison, Rajeev Pandey, Michael Considine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2023
SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector DifferentiationRachel S Helms, Alberto Marin-Gonzalez, Chirag H Patel, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Serine synthesis pathway upregulated by E-cadherin is essential for the proliferation and metastasis of breast cancersGeonhui Lee, Claudia Wong, Anna Cho, et al.
Cancer Research|July 3, 2024
E-Cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast CancerGeonhui Lee, Claudia Wong, Anna Cho, et al.
Science (New York, N.Y.)|November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasionRobert D Leone, Liang Zhao, Judson M Englert, et al.
Science Advances|November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrugRana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nature Communications|November 17, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosisSadiya Parveen, Jessica Shen, Shichun Lun, et al.
Science Immunology|March 14, 2025
QRICH1 mediates an intracellular checkpoint for CD8<sup>+</sup> T cell activation via the CARD11 signalosomeNicole M Carter, Wihib D Hankore, Yong-Kang Yang, et al.
Cancer Research Communications|September 2, 2022
Interrogation of T Cell-Enriched Tumors Reveals Prognostic and Immunotherapeutic Implications of Polyamine MetabolismR Alex Harbison, Rajeev Pandey, Michael Considine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2023
SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector DifferentiationRachel S Helms, Alberto Marin-Gonzalez, Chirag H Patel, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Serine synthesis pathway upregulated by E-cadherin is essential for the proliferation and metastasis of breast cancersGeonhui Lee, Claudia Wong, Anna Cho, et al.
Cancer Research|July 3, 2024
E-Cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast CancerGeonhui Lee, Claudia Wong, Anna Cho, et al.
Science (New York, N.Y.)|November 9, 2019
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasionRobert D Leone, Liang Zhao, Judson M Englert, et al.
Science Advances|November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrugRana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
Pageof 3